CoChat

GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R

The DOI matches its Crossref record; 52 of the 56 references it cites were found in a registry or an index.

Abstract

Obesity and diabetes are characterized by increased inflammation reflecting disordered control of innate immunity. We reveal a local intestinal intraepithelial lymphocyte (IEL)-GLP-1 receptor (GLP-1R) signaling network that controls mucosal immune responses. Glp1r expression was enriched in intestinal IEL preparations and copurified with markers of Tαβ and Tγδ IELs, the two main subsets of intestinal IELs. Exendin-4 increased cAMP accumulation in purified IELs and reduced the production of cytokines from activated IELs but not from splenocytes ex vivo. These actions were mimicked by forskolin, absent in IELs from Glp1r−/− mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action. Furthermore, Glp1r−/− mice exhibited dysregulated intestinal gene expression, an abnormal representation of microbial species in feces, and enhanced sensitivity to intestinal injury following administration of dextran sodium sulfate. Bone marrow transplantation using wild-type C57BL/6 donors normalized expression of multiple genes regulating immune function and epithelial integrity in Glp1r−/− recipient mice, whereas acute exendin-4 administration robustly induced the expression of genes encoding cytokines and chemokines in normal and injured intestine. Taken together, these findings define a local enteroendocrine-IEL axis linking energy availability, host microbial responses, and mucosal integrity to the control of innate immunity.

Overview

Integrity signals

Registry

Crossref · 10.2337/db14-1577

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 282

Metadata

Authors
Yusta, B., Baggio, L. L., Koehler, J., Holland, D., Cao, X., Pinnell, L. J., Johnson-Henry, K. C., Yeung, W., Surette, M. G., Bang, K. W. A., Sherman, P. M., & Drucker, D. J.
Affiliations
  • Mount Sinai Hospital (CA)
  • University of Toronto (CA)
  • Cell Biology Program, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
  • McMaster University (CA)
Corresponding author
Drucker, Daniel J.
Venue
Diabetes
Published
2015-03-03
Volume
64
Issue
7
Pages
2537-2549
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W1903699177
Cited by
282
References
56
Citations by year
2026: 25 · 2025: 45 · 2024: 34 · 2023: 20 · 2022: 32 · 2021: 29 · 2020: 20 · 2019: 29 · 2018: 16 · 2017: 18 · 2016: 7 · 2015: 6
FWCI
13.58
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Novo Nordisk Inc
  • Canadian Institutes of Health Research (MOP 123391, Novo Nordisk Inc)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Keywords
GLP-1 receptor agonists, exendin-4, exendin-9-39, intestinal intraepithelial lymphocytes, mucosal immunity, innate immunity, cAMP signaling, gut microbiota, intestinal injury, dextran sodium sulfate, bone marrow transplantation, obesity, cytokine and chemokine expression, epithelial barrier integrity
MeSH terms
Glucagon-Like Peptide-1 Receptor, Exenatide, Animals, Female, Immunity, Innate, Intestinal Mucosa, Lymphocytes, Male, Mice, Inbred C57BL, Peptides, Venoms, Signal Transduction, Cytokines, Receptors, Glucagon, Mice, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.